Brief: Alkermes Announces Agreement To Sell Ireland Facility To Novo Nordisk

Alkermes

14/12/2023 11:09

Dec 14 (Reuters) - Alkermes Plc  ALKS.O :
    * ALKERMES PLC ANNOUNCES AGREEMENT TO SELL ATHLONE, IRELAND
FACILITY TO NOVO NORDISK
    * ALKERMES PLC - PROPOSED DEAL FOR CASH PAYMENT OF $92.5
MILLION
    * ALKERMES PLC - TRANSACTION IS EXPECTED TO CLOSE IN
MID-2024,
SUBJECT TO CERTAIN CLOSING CONDITIONS
    * ALKERMES PLC - ALKERMES WILL CONTINUE TO RETAIN ALL
ROYALTY
REVENUES ASSOCIATED WITH PRODUCTS CURRENTLY MANUFACTURED AT
FACILITY
    * ALKERMES PLC - TRANSACTION IS EXPECTED TO BE OPERATING
COST-NEUTRAL TO ALKERMES
    * ALKERMES PLC - TRANSACTION IS EXPECTED TO YIELD
SIGNIFICANT
OPERATING COST BENEFIT AND CONTRIBUTE TO ENHANCED PROFITABILITY
    * ALKERMES PLC - CONTINUE TO MANUFACTURE VIVITROL, ARISTADA,
ARISTADA INITIO, LYBALVI, AT ITS WILMINGTON, OHIO MANUFACTURING
FACILITY

Source text for Eikon:  ID:nPn8vBqGCa 
Further company coverage:  ALKS.O 

 ((Reuters.Briefs@thomsonreuters.com;))